ifosfamide has been researched along with Inappropriate ADH Syndrome in 8 studies
Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.
Excerpt | Relevance | Reference |
---|---|---|
"A patient with a small-cell lung cancer (SCLC) developed an asymptomatic hyponatremia, with all features of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), two days after the start of his first cycle of chemotherapy with vindesine, ifosfamide and cisplatin." | 4.80 | Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review. ( Paridaens, R; Vanhees, SL; Vansteenkiste, JF, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cucchiari, D | 1 |
Bertuzzi, A | 1 |
Colombo, P | 1 |
De Sanctis, R | 1 |
Faucher, E | 1 |
Fusco, N | 1 |
Pellegrinelli, A | 1 |
Arosio, P | 1 |
Angelini, C | 1 |
Glezerman, IG | 1 |
Tho, LM | 1 |
Ferry, DR | 1 |
Ciaudo, M | 1 |
Chauvenet, L | 1 |
Audouin, J | 1 |
Rossert, J | 1 |
Favier, R | 1 |
Horellou, MH | 1 |
Bernadou, A | 1 |
Samama, M | 1 |
Tsujita, Y | 1 |
Iwao, N | 1 |
Makino, S | 1 |
Ohsawa, N | 1 |
Kirch, C | 1 |
Gachot, B | 1 |
Germann, N | 1 |
Blot, F | 1 |
Nitenberg, G | 1 |
Vanhees, SL | 1 |
Paridaens, R | 1 |
Vansteenkiste, JF | 1 |
Culine, S | 1 |
Ghosn, M | 1 |
Droz, JP | 1 |
1 review available for ifosfamide and Inappropriate ADH Syndrome
Article | Year |
---|---|
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Humans; Hyponatrem | 2000 |
7 other studies available for ifosfamide and Inappropriate ADH Syndrome
Article | Year |
---|---|
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Benzazepi | 2013 |
Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents, Alkylating; Antineoplastic | 2009 |
Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; I | 2005 |
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Cy | 1995 |
[Syndrome of inappropriate secretion of antidiuretic hormone and neurotoxicity induced by vincristine and alkylating agents during chemotherapy for malignant lymphoma of thyroid gland].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; C | 1998 |
Recurrent ifosfamide-induced hyponatraemia.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Cranial Nerve Neoplasms; Female; Humans; Hyponatremia | 1997 |
Inappropriate antidiuretic hormone secretion induced by ifosfamide.
Topics: Aged; Humans; Ifosfamide; Inappropriate ADH Syndrome; Male | 1990 |